Back
Intellia Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
NTLA
Intellia Therapeutics, Inc.
Last Price:
$11.64
Seasonality Move:
-8.61%
7 Day Trial
ALL ACCESS PASS
$
7
Intellia Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Intellia Therapeutics, Inc. has on average historically risen by 33.4% based on the past 9 years of stock performance.
-
Intellia Therapeutics, Inc. has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Intellia Therapeutics, Inc. Stock Undervalued?The current Intellia Therapeutics, Inc. [NTLA] share price is $12.00. The Score for NTLA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
NTLA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Intellia Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Intellia Therapeutics, Inc. has on average historically risen by 33.4% based on the past 9 years of stock performance.
Intellia Therapeutics, Inc. Stock Rating
Sell
36
Intellia Therapeutics, Inc. (NTLA)
is a Sell
Is Intellia Therapeutics, Inc. overpriced?
-
Intellia Therapeutics, Inc. has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Intellia Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
intelliatx.com
52-Week Data
52-Week High:
28.25
52-Week Low:
5.90
Prediction Charts
Market Cap:
1.4B
Price in USD:
12.00
Volume:
3.6M
Beta:
2.10
Technical Analysis
SMA50:
10.93
SMA100:
13.60
SMA200:
11.96
52-Wk Change:
30.29%
Stock Predictions
-
Is Intellia Therapeutics, Inc. stock public?Yes, Intellia Therapeutics, Inc. is a publicly traded company.
-
What is the Intellia Therapeutics, Inc. stock quote today?The Intellia Therapeutics, Inc. stock price is 12.00 USD today.
-
How to buy Intellia Therapeutics, Inc. stock online?You can buy Intellia Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-23 | 15.82 | 14.63 | 15.95 | 14.50 |
| Jan-26 | 14.38 | 13.95 | 14.70 | 13.86 |
| Jan-27 | 16.51 | 14.83 | 17.09 | 14.20 |
| Jan-28 | 14.97 | 13.82 | 15.00 | 13.59 |
| Jan-29 | 13.86 | 13.90 | 14.67 | 13.67 |
| Jan-30 | 13.46 | 13.15 | 13.97 | 12.94 |
| Feb-2 | 13.00 | 13.06 | 13.41 | 12.80 |
| Feb-3 | 13.15 | 13.05 | 13.76 | 12.51 |
| Feb-4 | 13.03 | 12.36 | 13.07 | 11.96 |
| Feb-5 | 11.98 | 11.09 | 12.20 | 10.94 |
| Feb-6 | 11.32 | 12.28 | 12.33 | 11.32 |
| Feb-9 | 12.00 | 12.49 | 12.50 | 11.76 |
| Feb-10 | 12.32 | 11.91 | 12.54 | 11.75 |
| Feb-11 | 11.89 | 12.00 | 12.04 | 11.36 |
Intellia Therapeutics, Inc. Earnings
Intellia Therapeutics, Inc. Earnings Report: Per Share Intellia Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intellia Therapeutics, Inc. Forecast Revenue Growth
Intellia Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Intellia Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $2.05 per share.
* Intellia Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.